Out­side re­view con­firms top Memo­r­i­al Sloan Ket­ter­ing ex­ec­u­tives flout­ed con­flicts-of-in­ter­est poli­cies — re­port

The up­per ech­e­lons of the Memo­r­i­al Sloan Ket­ter­ing (MSK) Can­cer Cen­ter have been charged with cul­ti­vat­ing a cul­ture of putting prof­its be­fore re­search and pa­tients by per­sis­tent­ly breach­ing con­flict-of-in­ter­est poli­cies in a re­view con­duct­ed by an in­de­pen­dent body.

The re­sults of the re­view — re­port­ed by the New York Times and ProP­ub­li­ca — so­lid­i­fies a sweep­ing in­ves­ti­ga­tion by the two me­dia or­ga­ni­za­tions last year that found var­i­ous top ex­ec­u­tives and board mem­bers from the lead­ing New York-based can­cer re­search and treat­ment cen­ter had prof­it­ed from re­la­tion­ships with drug­mak­ers, oth­er re­search out­fits and cor­po­rate board mem­ber­ships.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN